The 2020 Tang Prize in Biopharmaceutical Science is jointly awarded to Drs. Charles Dinarello, Marc Feldmann and Tadamitsu Kishimoto, “for the development of cytokine-targeting biological therapies for treatment of inflammatory diseases” that brought a ray of hope to hundreds of thousands of patients debilitated by this degenerative condition. The Tang Prize Foundation, Experimental Biology (EB) and National Cheng Kung University will co-host the 2020 Tang Prize Masters’ Forum on biopharmaceutical science, taking place from 9a.m. to 11:20 am. (GMT+8) Taiwan time, on September 22.
This forum features three 2020 laureates speaking on the topic, “Targeting the Hyperactive Immune System, from Autoimmune Disease to Cytokine Storms,” keeping us abreast of the latest development in biomedical science in the age of coronavirus.
To engage audiences around the world, this forum will be livestreamed on the Foundation’s official website (https://www.tang-prize.org/en/week.php?cat=94 ).
In addition, 2014 Tang Prize and 2018 Nobel Prize winners Dr. James P. Allison and Dr. Tasuku Honjo will also take part in the discussion, brainstorming with us to spot all the opportunities for the development of biopharmaceutical research that could be opened up because of this health crisis.